Prevalence and risk factors for upper gastrointestinal diseases in health check-up subjects: a nationwide multicenter study in Korea

References

• Jung KW, Won YJ, Oh CM, et al. Cancer Statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017;49:292–305.
   PubMedGoogle Scholar
• Kim N, Kim JW, Kim HJ, et al. Distribution of upper gastroduodenal diseases in health check-up subjects in 2006. Korean J Helicobacter Up Gastrointest Res. 2008;8:1–8.
   Google Scholar
• Park HK, Kim N, Lee SW, et al. The distribution of endoscopic gastritis in 25,536 heath check-up subjects in Korea. Korean J Helicobacter Up Gastrointest Res. 2012;12:237–243.
   Google Scholar
• Plummer M, Franceschi S, Vignat J, et al. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487–490.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53:354–361.
   PubMed Web of Science ®Google Scholar
• Fock KM, Talley N, Moayyedi P, et al. Asia–Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008;23:351–365.
   PubMed Web of Science ®Google Scholar
• McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362:1597–1604.
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–6740.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim HY, Kim NY, et al. Seroprevalence of Helicobacter pylori infection in asymptomatic people in Korea. Korean J Med. 2000;59:388–397.
   Google Scholar
• Kim YS, Baik GH. Epidemiology of Helicobacter pylori infection in Korea. Korean J Helicobacter Up Gastrointest Res. 2011;11:1–6.
   Google Scholar
• Joo YE, Park HK, Myung DS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7:303–310.
   PubMed Web of Science ®Google Scholar
• Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter. 2007;12:333–340.
   PubMed Web of Science ®Google Scholar
• Seo GS, Jeon BJ, Chung JS, et al. The prevalence of erosive esophagitis is not significantly increased in a healthy Korean population – could it be explained? A multi-center prospective study. J Neurogastroenterol Motil. 2013;19:70–77.
   PubMed Web of Science ®Google Scholar
• Lee SY, Lee KJ, Kim SJ, et al. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201.
   PubMed Web of Science ®Google Scholar
• Yang SY, Lee OY, Bak YT, et al. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study. Dig Dis Sci. 2008;53:188–193.
   PubMed Web of Science ®Google Scholar
• Kim JI, Kim SG, Kim N, et al. Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol. 2009;21:787–793.
   PubMed Web of Science ®Google Scholar
• Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2007;27:173–185.
   PubMed Web of Science ®Google Scholar
• Cai S, Garcia RLA, Masso GEL, et al. Uncomplicated peptic ulcer in the UK: trends from 1997 to 2005. Aliment Pharmacol Ther. 2009;30:1039–1048.
   PubMed Web of Science ®Google Scholar
• Dutta AK, Chacko A, Balekuduru A, et al. Time trends in epidemiology of peptic ulcer disease in India over two decades. Indian J Gastroenterol. 2012;31:111–115.
   PubMedGoogle Scholar
• Perez-Aisa MA, Del Pino D, Siles M, et al. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;21:65–72.
   PubMed Web of Science ®Google Scholar
• Xia B, Xia HH, Ma CW, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther. 2005;22:243–249.
   PubMed Web of Science ®Google Scholar
• Wu CY, Wu CH, Wu MS, et al. A nationwide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol. 2009;7:427–431.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol. 2007;42:1–15.
   PubMed Web of Science ®Google Scholar
• Jang HJ, Choi MH, Shin WG, et al. Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study. Dig Dis Sci. 2008;53:1527–1531.
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim N, Kim MS, et al. Factors affecting first-line triple therapy of Helicobacter pylori including CYP2C19 genotype and antibiotic resistance. Dig Dis Sci. 2014;59:1235–1243.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim N, Chung JI, et al. Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H. pylori in South Korea. Helicobacter. 2008;13:288–294.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Kim N, Lee BH, et al. Risk factors for development and recurrence of peptic ulcer disease. Korean J Gastroenterol. 2010;56:220–228.
   PubMedGoogle Scholar
• Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology. 2000;119:521–535.
   PubMed Web of Science ®Google Scholar
• Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol. 2001;15:705–722.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009;29:938–946.
   PubMed Web of Science ®Google Scholar
• Bae S, Kim N, Kang JM, et al. Incidence and 30-day mortality of peptic ulcer bleeding in Korea. Eur J Gastroenterol Hepatol. 2012;24:675–682.
   PubMed Web of Science ®Google Scholar
• Wang FW, Tu MS, Mar GY, et al. Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan. World J Gastroenterol. 2011;17:1199–1203.
   PubMed Web of Science ®Google Scholar
• Johnsen R, Forde OH, Straume B, et al. Aetiology of peptic ulcer: a prospective population study in Norway. J Epidemiol Community Health. 1994;48:156–160.
   PubMed Web of Science ®Google Scholar